share_log

Jefferies Maintains Hold on Nektar Therapeutics, Raises Price Target to $1

Moomoo 24/7 ·  Mar 6 09:44

Jefferies analyst Roger Song maintains Nektar Therapeutics (NASDAQ:NKTR) with a Hold and raises the price target from $0.5 to $1.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment